Inventor · disambiguated record
Bryan Chan
Also filed as: CHAN BRYAN · CHAN BRYAN K · CHAN BRYAN KA IP
29 granted patents·7 pending applications·225 citations·filing 2009–2025
96Inventor score
Top patents by PatentIndex Score
36 records- 0195US11566003B2Isoquinolines as inhibitors of HPK1GENENTECH INC·Filed 2020·Granted Jan 31, 2023·4 cites·31 claims
- 0294US9212173B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·18 cites·3 claims
- 0393US8815882B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsBAKER-GLENN CHARLES·Filed 2011·Granted Aug 26, 2014·34 cites·22 claims
- 0493US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0592US9212186B2Bicyclic pyrazole LRRK2 small molecule inhibitorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·11 cites·18 claims
- 0690US10407424B2Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2018·Granted Sep 10, 2019·5 cites·72 claims
- 0790US8791130B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Jul 29, 2014·18 cites·21 claims
- 0889US9145402B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Sep 29, 2015·15 cites·20 claims
- 0988US9139566B2Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (PET) imaging for LRRK2GENENTECH INC·Filed 2012·Granted Sep 22, 2015·6 cites·12 claims
- 1088US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 1188US8796296B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 5, 2014·14 cites·21 claims
- 1286US9890152B2Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2015·Granted Feb 13, 2018·7 cites·29 claims
- 1386US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 1485US8394796B2Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of useCASTANEDO GEORGETTE·Filed 2012·Granted Mar 12, 2013·8 cites·20 claims
- 1584US9951064B2Azaindazole compounds as inhibitors of T790M containing EGFR mutantsGENENTECH INC·Filed 2016·Granted Apr 24, 2018·5 cites·15 claims
- 1683US8563540B2Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Oct 22, 2013·6 cites·9 claims
- 1783US8173650B2Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of useCASTANEDO GEORGETTE·Filed 2010·Granted May 8, 2012·7 cites·21 claims
- 1881US11034692B1Naphthyridines as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Jun 15, 2021·1 cites·20 claims
- 1980US11612606B28-aminoisoquinoline compounds and uses thereofGENENTECH INC·Filed 2019·Granted Mar 28, 2023·2 cites·29 claims
- 2078US8569281B2Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRKCHAN BRYAN K·Filed 2011·Granted Oct 29, 2013·9 cites·9 claims
- 2178US8440651B2Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2011·Granted May 14, 2013·4 cites·8 claims
- 2275US2024368170A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2373US2025074881A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 2468US12110276B2Pyrazolo compounds and methods of use thereofGENENTECH INC·Filed 2022·Granted Oct 8, 2024·0 cites·28 claims
- 2567US12275745B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Granted Apr 15, 2025·0 cites·20 claims
- 2667US10952995B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2019·Granted Mar 23, 2021·0 cites·32 claims
- 2764US11944606B2Azaindoles as inhibitors of HPK1GENENTECH INC·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
- 2862US2022073520A1Cinnoline compounds and uses thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2958US2025171464A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 3054US12208088B2Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereofGENENTECH INC·Filed 2021·Granted Jan 28, 2025·0 cites·29 claims
- 3154US2018282282A1Isoquinolines as inhibitors of hpk1GENENTECH INC·Filed 2018·Application pending·0 cites
- 3253US12473301B2Isoquinoline compounds for the treatment of cancerGENENTECH INC·Filed 2021·Granted Nov 18, 2025·0 cites·18 claims
- 3353US12378249B2Isoquinoline compounds and uses thereofGENENTECH INC·Filed 2021·Granted Aug 5, 2025·0 cites·25 claims
- 3453US12297210B2Naphthyridine compounds and uses thereofGENENTECH INC·Filed 2021·Granted May 13, 2025·0 cites·15 claims
- 3550US2011201599A1CDK ModulatorsEXELIXIS INC·Filed 2009·Application pending·0 cites
- 3643US2014288043A1Pyrazolopyridine compoundsGENENTECH INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bryan Chan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →